AVAH

Aveanna Healthcare Holdings Inc. (AVAH) Economic Moat Analysis (2026)

Invetso Score: 5.8/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Profitability Returns

AVAH continues to generate solid returns with ROIC at 16.8% and ROE at 150.2%, supported by an operating margin of 11.1% and gross margin of 32.0%.

Asset efficiency remains healthy, with ROA at 13.0% and asset turnover at 1.24x, indicating the business still converts its asset base into earnings reasonably well.

Cash Flow Capital Efficiency

Free cash flow remains positive, with FCF yield at 5.9% and FCF conversion from operating cash flow at 98.4%, suggesting strong cash realization.

Capital intensity appears low, with capex at just 1.5% of operating cash flow and capex-to-revenue near zero, supporting cash generation.

Balance Sheet Financial Risk

Leverage remains elevated, with net debt to EBITDA at 4.16x and debt to equity at 4.67x, which limits financial flexibility.

Liquidity is adequate but not strong, as the current ratio is 1.16x and the cash ratio is 0.24x, leaving limited cushion.

Moat Durability Competitive Position

The company’s profitability and returns suggest some competitive resilience, but the moat is not clearly wide given the modest operating margin and leverage burden.

A high proportion of intangible assets (65.3% of total assets) and a negative tangible book value indicate the business is still heavily reliant on non-tangible assets and goodwill-like balance sheet support.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Aveanna Healthcare Holdings Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →